Sunshine Heart Inc news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

SSH 4.24 +0.08 (1.92%)
price chart
Sunshine Heart's new device is heartening news
Sunshine Heart Inc. is creating plenty of buzz with a new heart assist device that could reverse heart damage in some patients.
Related articles »  
Canaccord Pounds the Table on Sunshine Heart Inc
Canaccord Genuity analyst Jason Mills was out pounding the table on Sunshine Heart Inc (NASDAQ:SSH) Thursday, reiterating a Buy rating and a $7.50 price target, which represents a potential upside of 82.5% from where the stock is currently trading.
Sunshine Heart Inc.: Sunshine Heart to Release Fourth Quarter and Year-End ...  The Wall Street Transcript
Sunshine Heart Receives a Buy from Cowen & Co.  Analyst Ratings
Sunshine Heart (SSH) Stock Drops Today After Suspending Study Enrollment
"We rate SUNSHINE HEART INC (SSH) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of ...
Sunshine Heart Provides Update on U.S. Pivotal Study of C-Pulse(R) Heart ...  GlobeNewswire (press release)
Sunshine Heart Provides Update on US Pivotal Study of C-Pulse(R) Heart ...  MarketWatch
Sunshine Heart, Inc. Secures Up to $10 Million in Growth Capital From Silicon ...
Sunshine Heart, Inc. SSH, -24.67% is an early-stage medical device company focused on developing, manufacturing and commercializing the C-Pulse System for treatment of Class III and ambulatory Class IV heart failure.
Here's Why Sunshine Heart Inc (SSH) Stock is Trending Up By 18% Today
Sunshine Heart Inc (NASDAQ:SSH) has received an unrestricted approval for holding a provisional analysis of the COUNTER HF study from the US Food and Drug Administration (FDA), the company announced on Wednesday.
Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal ...  GlobeNewswire (press release)
Sunshine Heart Receives FDA Approval for Interim Analysis of US Pivotal ...  MarketWatch
Healthcare Stocks Seeking Failure - Sunshine Heart Inc (NASDAQ:SSH), Geron ...
Sunshine Heart Inc. (SSH), declared an update on COUNTER HF(TM), the Corporation's U.S. pivotal study which is a prospective, randomized, multi-center, controlled study evaluating the safety and efficacy of the C-Pulse system for the treatment of NYHA ...
Sunshine Heart stops C-Pulse trial to investigate patient deaths
Sunshine Heart Inc., an Eden Prairie company that is testing a device to treat severe heart failure, has halted enrollment in its pivotal study after four patients died.
Sunshine Heart to Release Fourth Quarter and Year-End 2014 Results on March ...  MarketWatch
Sunshine Heart Provides Corporate Update
EDEN PRAIRIE, Minn., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today provided an update on the Company's U.S.
Healthcare Stocks Gaining Streaks Highlights: Sunshine Heart (NASDAQ:SSH ...
Sunshine Heart Inc (NASDAQ:SSH)'s shares picked up 2.86%, and closed at $5.75, during the last trading session, soon after the news release that an early-stage medical device company, declared it has received unconditional approval from the FDA to ...
Sunshine Heart to Present at the Cowen and Company 35th Annual Health Care ...
EDEN PRAIRIE, Minn., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Executive Officer, Dave Rosa, is scheduled to present at the Cowen and Company 35th Annual Health Care Conference in Boston, ...